Enhanced immunostimulatory and antitumor activity of different derivatives of κ-carrageenan oligosaccharides from Kappaphycus striatum

Journal of Applied Phycology

Volumn 23, Issue 1, 2011, Pages 59-65

  Yuan, Huamao ^a   Song, Jinming ^a   Li, Xuegang ^a   Li, Ning ^a   Liu, Song ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Antitumor; Carrageenan; Chemical modification; Derivatives; Immunomodulation; Oligosaccharides

Indexed keywords

KAPPAPHYCUS STRIATUM; MUS; OVIS ARIES;

EID: 79951554625     PISSN: 09218971     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10811-010-9536-4     Document Type: Article

References (21)

1. Bland EJ, Keshavarz T, Bucke C (2004) The influence of small oligosaccharides on the immune system. Carbohydr Res 339: 1673-1678.
2. Bobek V, Boubelik M, Fišerová A, Ľuptovvová M, Vannucci L, Kacprzak G, Kolodzej J, Majewski AM, Hoffman RM (2005) Anticoagulant drugs increase natural killer cell activity in lung cancer. Lung Cancer 47: 215-223.
3. Chen HM, Yan XJ, Lin J, Wang F, Xu WF (2007) Depolymerized products of λ-carrageenan as a potent angiogenesis inhibitor. J Agric Food Chem 55: 6910-6917.
4. Ehrke MJ (2003) Immunomodulation in cancer therapeutics. Int Immunopharmacol 3: 1105-1119.
5. Franz G, Pauper D, Alban S (2000) Bioactive carbohydrate polymers. Proceedings of the Phytochemical Society of Europe, vol 44. Kluwer Academic Publishers, Dordrecht, Boston pp 47-58.
6. Hoffman R (1993) Carrageenans inhibit growth-factor binding. Biochem J 289: 331-334.
7. Koyanagi S, Tanigawa N, Nakagawa H, Soeda S, Shimeno H (2003) Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol 65: 173-179.
8. Li XY (2000) Immunomodulating components from chinese medicines. Pharm Biol 38(Supp): 33-40.
9. Paper DH, Vogl H, Franz G (1995) Defined carrageenan derivatives as angiogenesis inhibitors. Macromol Symp 99: 219-225.
10. Parish CR, Freeman C, Brown KJ, Francis DJ, Cowden WB (1999) Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Can Res 59: 3433-3441.
11. Rabinovich GA, Gabrilovich D, Sotomayor EM (2007) Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 25: 267-296.
12. Saksena R, Deepak D, Khare A, Sahai R, Tripathi LM, Srivastava VML (1999) A novel pentasaccharide from immunostimulant oligosaccharide fraction of buffalo milk. Biochim Biophys Acta 1428: 433-445.
13. Salem ML, Matsuzaki G, Madkour GA, Nomoto K (1999) Beta-estradiol-induced decrease in IL-12 and TNF-α expression suppresses macrophage functions in the course of Listeria monocytogenes infection in mice. Int J Immunopharmacol 21: 481-497.
14. Simpson MA, Gozzo JJ (1978) Spectrophotometric determination of lymphocyte mediated sheep red blood cell hemolysis in vitro. J Immunol Meth 21: 159-165.
15. Soeda S, Kozako T, Iwata K, Shimeno H (2000) Oversulfated fucoidan inhibits the basic fibroblast growth factor-induced tube formation by human umbilical vein endothelial cells: its possible mechanism of action. Biochim Biophys Acta 1497: 127-134.
16. Weymouth-Wilson AC (1997) The role of carbohydrates in biologically active natural products. Nat Prod Rep 14: 99-110.
17. Yashizawa Y, Ametani A, Tsunehiro J, Numura K, Itoh M, Fukui F (1995) Macrophage stimulation activity of the polysaccharide fraction from a marine alga (Porphyra yezoensis): structure-function relationship and improved solubility. Biosci Biotech Biochem 59: 1933-1937.
18. Yuan HM, Song JM (2005) Preparation, structural characterization and in vitro antitumor activity of kappa-carrageenan oligosaccharide fraction from Kappaphycus striatum. J Appl Phycol 17: 7-13.
19. Yuan HM, Zhang WW, Li XG, Lü XX, Li N, Gao XL, Song JM (2005) Preparation and in vitro antioxidant activity of κ-carrageenan oligosaccharides and their oversulfated, acetylated, and phosphorylated derivatives. Carbohydr Res 340: 685-692.
20. Yuan HM, Song JM, Li XG, Li N, Dai JC (2006a) Immunomodulation and antitumor activity of κ-carrageenan oligosaccharides. Canc Lett 243: 228-234.
21. Yuan HM, Song JM, Zhang WW, Li XG, Li N, Gao XL (2006b) Antioxidant activity and cytoprotective effect of κ-carrageenan oligosaccharides and their different derivatives. Bioorg Med Chem Lett 16: 1329-1334.